Hilleman Insights
Trade
The World Faces More Vaccine Challenges Than Just COVID-19
After the traumatic experiences of the first year of COVID-19 pandemic we now have an idea of what a world without vaccines could be like.
Trade
The Threat of Infectious Diseases in Asia Pacific
Asia Pacific is home to more than half of the world’s population and bears a significant burden of infectious disease, particularly in the low-and-middle-income countries (LMICs).
White Paper
Vaccines, Today and Tomorrow
Hilleman Laboratories establishes pilot manufacturing facility for vaccine development in Singapore with support from Singapore Economic Development Board
Trade
The Importance of Innovation to Improve Vaccine Equity and Access for Future Pandemics
The COVID-19 pandemic has shown science at its best as we witnessed the rapid development of vaccines
